Table 2 Clinicopathological information of 350 HCC cases in TCGA dataset classified by the tumor ploidy determined using the HIPT2_unfrozen2 model
Variables | Diploid | Polyploid | p value | ||
|---|---|---|---|---|---|
Number of cases | 123 | 227 | - | Â | |
Age | 62 ± 12.5 | 60 ± 13.4 | 0.35 | 1 | |
Sex (Proportion of male) | 72.4 | 65.4 | 0.18 | 2 | |
Tumor stage | T1 | 75 | 98 | 0.002 | 4 |
T2 / T2a / T2b | 23 | 65 | |||
T3 / T3a / T3b | 22 | 52 | |||
T4 | 1 | 11 | |||
N.D. | 2 | 1 | - | Â | |
LN metastasis | N0/N1/N.D. | 89/0/34 | 154/3/70 | 0.48 | 2 |
Distant metastasis | M0/M1/N.D. | 93/1/29 | 162/2/63 | 1 | 2 |
Pathological stage | Stage I | 72 | 92 | 0.005 | 4 |
Stage II | 23 | 60 | |||
Stage III / IIIA / IIIB / IIIC | 22 | 56 | |||
Stage IV / IVA / IVB | 1 | 4 | |||
Tumor grade | G1/G2/G3/G4/N.D. | 21/69/29/3/1 | 25/99/89/10/4 | 0.001 | 4 |
Child-Pugh grade | A/B/N.D. | 97/8/18 | 112/13/102 | 0.47 | 2 |
Vascular invasion | Macro/Micro/None/N.D. | 6/25/85/7 | 9/63/111/44 | 0.07 | 4 |
Fibrosis | 0 - No Fibrosis | 42 | 31 | 0.26 | 4 |
1,2 - Portal Fibrosis | 9 | 19 | |||
3,4 - Fibrous Speta | 14 | 14 | |||
5 - Nodular Formation and Incomplete Cirrhosis | 3 | 5 | |||
6 - Established Cirrhosis | 30 | 35 | |||
N.D. | 25 | 123 | - | Â | |
Serum prothrombin time (sec) | 1.1 ± 4.89 | 1.1 ± 5.05 | 0.294 | 3 | |
Serum alpha fetoprotein (ng/mL) | 9 ± 14255 | 23 ± 162348 | 0.040 | 3 | |
Serum albumin (g/dL) | 4.05 ± 5.5 | 4 ± 1.03 | 0.502 | 3 | |
Platelet (Ă—103/μL) | 212.5 ± 61667 | 211 ± 86405.6 | 0.675 | 3 | |
Serum total bilirubin (mg/dL) | 0.7 ± 1.49 | 0.7 ± 1.63 | 0.549 | 3 | |